| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.01B | — | +32.2% |
| Cost of Revenue | $209.2M | — | +32.7% |
| Gross Profit | $797.2M | — | +32.0% |
| R&D Expense | $435.3M | — | +27.6% |
| SG&A Expense | $74.8M | — | +22.6% |
| Operating Income | $7.3M | — | +159.0% |
| Interest Expense | $1.0M | — | -48.1% |
| Pre-tax Income | $58.9M | — | +85.3% |
| Income Tax | $6.4M | — | -11.2% |
| Net Income | $52.6M | — | +113.4% |
| EPS (Basic) | $0.15 | — | +114.3% |
| EPS (Diluted) | $0.15 | — | +114.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $426.4M | +6.2% | -60.5% |
| Accounts Receivable | $680.4M | -8.2% | +38.8% |
| Current Assets | $5.63B | +4.5% | +10.8% |
| Total Assets | $6.95B | +4.6% | +15.7% |
| Current Liabilities | $1.66B | +4.1% | -10.7% |
| Total Liabilities | $2.96B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $334.6M | — | +23.2% |
| Capital Expenditures | $11.4M | — | +29.8% |
| Investing Cash Flow | -$314.8M | — | +29.0% |
| Financing Cash Flow | $9.7M | — | +487.5% |
| Free Cash Flow | $323.3M | — | +23.0% |
| -4.2% |
| Stockholders' Equity | $3.99B | +6.9% | +36.7% |